![]() |
市场调查报告书
商品编码
1624441
2024 至 2031 年诊断导管市场(按地区)Diagnostic Catheter Market By Product (Imaging, Non-imaging), Application (Cardiology, Urology, Gastroenterology, Neurology), End-User (Hospitals, Diagnostic & Imaging Centers), & Region for 2024- 2031 |
慢性病发病率的增加、老年人口的增加、微创手术的需求增加以及肾臟和心血管疾病发病率的上升正在推动诊断导管市场的发展。据 Verified Market Research 分析师称,诊断导管市场规模估计预计将在 2024 年达到 72.6 亿美元,低于 2019 年的约 43.9 亿美元。
由于诊断准确性和精确度的提高,诊断导管中新技术的持续使用,例如 MRI 相容导管和超音波引导导管,也在推动市场的发展。这将使市场在 2024 年至 2031 年期间的复合年增长率达到 6.50%。
诊断导管市场定义/概述诊断导管是放置在体内用于观察和诊断各种疾病的专用医疗设备。这些导管用于血管造影等成像程序,其中可以注射造影剂以改善成像过程中动脉和器官的可见性。
此外,诊断导管在医疗领域的应用十分广泛,包括心臟科(用于分析心臟)、泌尿科(用于检查泌尿系统疾病)、胃肠病学(用于评估消化系统疾病)以及神经病学(用于检查神经系统疾病)。它能够提供重要的诊断讯息,使其成为现代医学必不可少的工具。
心血管疾病发生率的增加是诊断导管市场的主要驱动力。根据世界卫生组织(WHO)的数据,心血管疾病是全球最大的死亡原因,每年约导致1,790万人死亡。根据美国心臟协会2021年心臟病和中风统计更新,美国 48% 的成年人患有心血管疾病。这种高频率要求更频繁地使用诊断导管以确保正确的诊断和治疗计划。
全球人口老化正在增加对诊断导管的需求,因为老年人更容易感染各种需要透过导管诊断的疾病。根据联合国《2019年世界人口前景》报告,到2050年,每六人中就有一人年龄超过65岁(16%),高于每十一个人中就有一人(9%)。在北美和欧洲,到 2050 年这数字预计将达到四分之一。预计这种人口变化将增加对导管诊断程序的需求。
此外,导管技术和相关的成像技术也在不断发展,扩大了诊断导管的应用范围并提高了其有效性。 FDA 在 2020 年批准了 22 种新型心血管设备,其中几种使用了先进的导管技术。根据医疗器材创新联盟的数据,全球医疗器材产业预计2021年至2028年期间的复合年增长率为5.4%,2028年达到7,198亿美元。这种成长在一定程度上得益于导管等诊断技术的进步,这些技术在各种医疗保健领域中得到越来越广泛的应用。
诊断导管市场因先进设备的高成本而受到严重限制。创建和製造先进的诊断导管需要昂贵的材料和复杂的设计,从而增加了生产成本。这导致最终消费者的价格上涨并限制了市场进入,特别是在医疗预算有限的欠发达国家。
此外,诊断导管市场正面临技能短缺的问题。正确使用诊断导管需要专门的训练和经验,但并非所有医疗保健机构都能提供这些训练和经验。这种短缺限制了这些设备的采用,特别是在农村和服务不足的地区,从而影响了整体市场的成长。
The increasing frequency of chronic ailments, the growing elderly population, the growing desire for less invasive operations, and the rising incidence of kidney and cardiovascular disorders are all driving the diagnostic catheters market. According to the analyst from Verified Market Research, the diagnostic catheter market is estimated to reach a valuation of USD 7.26 Billion over the forecast subjugating around USD 4.39 Billion valued in 2024.
Due to their increased diagnostic accuracy and precision, the market is also being driven by the increasing use of new technologies in diagnostic catheters, such as MRI-compatible and ultrasound-guided catheters. It enables the market to grow at aCAGR of 6.50% from 2024 to 2031.
Diagnostic Catheter Market: Definition/Overview
A diagnostic catheter is a specialized medical device that is placed into the body to help visualize and diagnose various medical diseases. These catheters are employed in imaging procedures like angiography, where they allow for the injection of contrast chemicals to improve the visibility of blood arteries and organs during imaging examinations.
Furthermore, diagnostic catheters have a wide range of applications in medicine, including cardiology for analyzing heart ailments, urology for studying urinary tract concerns, gastroenterology for evaluating digestive illnesses, and neurology for exploring neurological diseases. Their ability to deliver vital diagnostic information makes them indispensable instruments in modern medicine.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
The increasing frequency of cardiovascular illnesses is a major driver of the diagnostic catheter market. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death worldwide, killing an estimated 17.9 million people each year. According to the American Heart Association's 2021 Heart Disease and Stroke Statistics update, 48% of all adults in the United States suffer from cardiovascular disease. This high frequency needs more frequent use of diagnostic catheters to ensure correct diagnosis and treatment planning.
The global aging population is increasing demand for diagnostic catheters, as older people are more susceptible to different ailments that necessitate catheter-based diagnosis. According to the United Nations World Population Prospects 2019 report, by 2050, one in every six individuals will be beyond the age of 65 (16%), up from one in every eleven (9%). In North America and Europe, this rate is expected to reach one in every four people by 2050. This demographic shift is projected to boost the need for diagnostic treatments involving catheters.
Furthermore, catheter technology and accompanying imaging techniques are constantly evolving, expanding diagnostic catheter uses and improving their efficacy. The FDA authorized 22 novel cardiovascular devices in 2020, several of which use sophisticated catheter technologies. According to the Medical Device Innovation Consortium, the worldwide medical device industry is predicted to increase at a 5.4% CAGR between 2021 and 2028, reaching $719.8 billion by 2028. This growth is being driven in part by advances in diagnostic technology, such as catheters, which are becoming more widely used in a variety of medical operations.
The high cost of advanced equipment is a significant restriction on the diagnostic catheter market. The creation and manufacturing of sophisticated diagnostic catheters require expensive materials and elaborate designs, which raises production costs. This results in increased prices for end consumers, limiting market access, especially in underdeveloped countries where healthcare budgets are constrained.
Furthermore, the diagnostic catheter market faces a problem due to a skills shortage. The proper use of diagnostic catheters necessitates specific training and experience, which are not easily available in all healthcare settings. This shortage restricts the adoption of these devices, particularly in rural or underserved areas, affecting overall market growth.
According to VMR analyst, the diagnostic imaging catheter segment is expected to dominate within the diagnostic catheter market during the forecast period. The increasing frequency of chronic diseases, especially cardiovascular and neurological disorders, necessitates the use of improved diagnostic technologies for optimal therapy. As these disorders become more widespread, the demand for imaging catheters that provide precise and detailed diagnostic information rises, boosting market expansion and reinforcing the segment's dominant position.
The developments in imaging technologies that improve the capabilities of diagnostic imaging catheters are another important driver. Improvements in image resolution, real-time imaging, and integration with other diagnostic modalities have increased the effectiveness and attraction of these catheters to healthcare practitioners. These technical advancements not only improve patient outcomes but also encourage the use of imaging catheters in clinical settings.
Furthermore, the increasing number of imaging and diagnostic centers worldwide is critical to the segment's growth. As healthcare systems extend their diagnostic capacities, there is a greater demand for sophisticated imaging catheters that can match these facilities' requirements. This tendency is especially prominent in emerging nations, where healthcare infrastructure investments are increasing, reinforcing the diagnostic imaging catheter segment's dominance.
The cardiology segment is estimated to hold the largest share of the diagnostic catheter market during the forecast period due to the increasing frequency of cardiovascular disorders. As cardiovascular disease remains the top cause of death worldwide, there is an increasing demand for improved diagnostic technologies. Diagnostic catheters make crucial operations like angiography easier, allowing healthcare providers to precisely detect and treat cardiac problems, which is why they are so often used in cardiology.
Advances in catheter technology have enabled less invasive methods of diagnosing and treating cardiovascular problems, which are preferred by both patients and healthcare practitioners. These treatments often result in faster recovery times and hospital stays, driving up demand for diagnostic catheters in cardiology applications.
Furthermore, technological developments in imaging techniques provide a substantial contribution to the cardiology segment's growth. Enhancements to diagnostic catheter imaging capabilities improve the accuracy and effectiveness of cardiovascular examinations. These innovations not only improve diagnosis and treatment planning but also raise the overall efficiency of cardiovascular care, maintaining the cardiology segment's dominant position in the diagnostic catheter market.
North America is estimated to dominate the diagnostic catheter market during the forecast period. North America, particularly the United States, has a high burden of cardiovascular illness, which drives demand for diagnostic catheters. According to the American Heart Association's 2021 Heart Disease and Stroke Statistics update, heart disease kills approximately 655,000 Americans each year, accounting for one out of every four fatalities. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most frequent type of heart disease, accounting for 365,914 deaths in 2017. Because of the high frequency of cardiovascular disorders, diagnostic catheters are used regularly to ensure appropriate diagnosis and treatment.
Furthermore, North America's advanced healthcare infrastructure and significant healthcare spending help to drive the diagnostic catheter market in this region. According to the Centers for Medicare and Medicaid Services, healthcare spending in the United States increased by 9.7% in 2020 to $4.1 trillion, or $12,530 per person. Health spending made up 19.7% of the nation's GDP. This high healthcare spending allows for higher use of new medical technologies, such as sophisticated diagnostic catheters.
The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia Pacific region's population is rapidly aging, creating the need for diagnostic catheters. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region's elder population (aged 65 and more) is predicted to more than double from 535 million in 2015 to around 1.3 billion by 2050. This demographic transition coincides with an increase in the prevalence of chronic diseases. According to the World Health Organization, cardiovascular illnesses cause 31% of all fatalities in the Western Pacific Region, accounting for an estimated 6.7 million deaths each year. The increasing illness load is driving the demand for catheter-based diagnostic catheters.
Furthermore, the Asia Pacific region is experiencing tremendous increases in healthcare infrastructure and investment, which is pushing the adoption of modern medical technologies such as diagnostic catheters. According to the World Bank, health expenditure as a proportion of GDP in East Asia and the Pacific rose from 6.4% in 2010 to 7.1% in 2018. In South Asia, it increased from 3.5% to 3.9% over the same period. The Asian Development Bank predicts that healthcare spending in Asia will reach $2.4 trillion by 2030, a 250% increase over 2015 figures. This increasing investment allows healthcare facilities to obtain and use more sophisticated diagnostic technologies, such as improved catheter systems.
The diagnostic catheter market is competitive due to rapid technical improvements and a focus on product differentiation. Companies are investing extensively in R&D to innovate and improve diagnostic catheter performance, including imaging enhancements and the development of customized catheters for a variety of medical purposes.
Some of the prominent players operating in the diagnostic catheter market include:
Medtronic plc
Boston Scientific Corporation
Abbott
Johnson & Johnson
Koninklijke Philips N.V.
Terumo Corporation
Bard, Inc.
Edwards Lifesciences Corporation
Braun Melsungen AG
Cardinal Health, Inc.
Diagnostic Catheter Market Latest Developments:
In September 2022, Philips introduced the Verisight Pro, a real-time 3D intracardiac echocardiography system. At Baptist Health's Miami Cardiac & Vascular Institute in Florida, the ICE catheter was effectively used to treat patients with structural heart disease during minimally invasive image-guided treatments.